Prevalence, resistance profile of ESKAPEE pathogens, and molecular detection of PMQR-associated genes among Levofloxacin-resistant gram-negative ESKAPEE isolates from critically-ill patients Authors: Sylvana Nady Gaber, Rasha H Bassyouni, Ahmed Ashraf Wegdan, Hagar Saad Abd-elrahman, Ahmed Fathy Elkhateeb, Joseph Makram Botros, Mahmoud A F Khalil, Hanaa Mohamed Eid Moawad Published: 2026 ABSTRACT AbstractBackgroundESKAPEE pathogens are characterized with rapid emergence of antibiotic resistance.AimTo detect the prevalence, resistance profile of ESKAPEE pathogens, and to analyze the Plasmid-Mediated Quinolone Resistance (PMQR)-associated genes among Levofloxacin-resistant gram-negative ESKAPEE pathogens isolated from critically ill patients in Fayoum University Hospitals, Egypt.MethodsA cross-sectional study was conducted from August 2021 to July 2022. Different specimens were collected and cultured on bacteriological media according to their respective sample sources. The identification of ESKAPEE isolates was performed according to standard microbiological methods. Antimicrobial susceptibilities were determined using Kirby-Baur disk diffusion method. The minimum inhibitory concentration (MIC) of levofloxacin was determined by microdilution method. Molecular identification of PMQR genes in Gram negative ESKAPEE isolates was performed by PCR.ResultsEighty-one samples were collected from 72 patients enrolled in the study. Eighty-four isolates were recovered, from them ESKAPEE pathogens represent 79/84 (94%) of all isolates. Enterococcus faecium was the predominant organism (21.4%). 77.8% of E. faecium were vancomycin-resistant Enterococcus (VRE). Also, 80% of P. aeruginosa, 83.3% of E. coli and 71.4% of K. pneumoniae isolates were extensively drug resistant (XDR). qnrB [78.9% (30/38)] was the most frequently detected gene among ESKAPEE pathogens. Most tested isolates (86.8%) have more than one PMQR gene.ConclusionsA high prevalence of ESKAPEE organisms was detected in ICU infected patients. qnrB was the most frequently PMQR detected genes.Keywords: ESKAPEE, Intensive care units, Plasmid-mediated quinolone resistant genes Introduction The acronym ESKAPE includes E. faecium, S. aureus, K. pneumoniae, A. baumannii, P. aeruginosa, and Enterobacter species (spp.). These pathogens can cause life-threatening hospital-acquired infections (HAIs) in critically ill patients [1]. Some studies added Escherichia coli to ESKAPE group highlighting its relevant antibiotic resistance rates and creating the acronym ESKAPEE [2, 3]. ESKAPEE organisms were accountable for over 80% of global deaths [4]. They can adapt for survival in the clinical setting and have miscellaneous methods for acquiring resistance determinants [5]. Carrying the resistant genes and the misuse of antimicrobials confer multidrug-resistant (MDR), extensive drug resistant (XDR), or pan drug-resistant (PDR) infection of ESKAPEE isolates [6, 7]. Quinolones block the action of two principal bacterial enzymes, type II topoisomerases, and topoisomerase IV, resulting in DNA synthesis suppression [8]. Quinolones approved for use in either human or veterinary medicine, have been prescribed to treat different conditions, [9]. However, due to the extensive use of quinolones, quinolone-resistant bacterial strains have been steadily increasing [10]. There are three different mechanisms of quinolone resistance: chromosomal mutations in coding genes of the GyrA subunits of topoisomerase II and ParC of topoisomerase IV. Mutations are also associated with the reduction of the intra-cytoplasmic concentration by overexpression of efflux pumps or the reduction of the membrane permeability [11]. Resistance genes: plasmid-mediated quinolone resistance (PMQR); is due to Qnr’s encoded proteins that protect topoisomerase II and topoisomerase IV. Also, AAC (6´)-lb-cr acetylates quinolones increase the outflow of quinolones [12]. Regarding PMQR genes, the first gene was (qnrA). Other plasmid-mediated resistance mechanisms were later reported (qnrB, qnrS, and qnrC), (aac(6´)-Ib-cr, and active efflux by QepA [13]. qnr genes are encoding resistance to chloramphenicol, trimethoprim, and β-lactam [14–16]. QepA, QacA, and QacBIII are proton-dependent efflux pumps [17]. Also, the CrpP enzyme is involved in the reduction of ciprofloxacin, norfloxacin, and moxifloxacin susceptibility. The crpP gene has been recognized in P. aeruginosa, E. coli, A. baumannii, and K. pneumoniae [11]. The increase in MDR ESKAPEE pathogens has become a noteworthy global health issue. Studying these pathogens is essential to understanding their mechanisms of resistance and developing new strategies to combat them. Also, quinolones are still clinically precious, but their use has been constrained by the emergence of resistance [18]. This study aimed to detect the prevalence, resistance profile of ESKAPEE pathogens and to analyze the Plasmid-Mediated Quinolone Resistance (PMQR)-associated genes among Levofloxacin-resistant gram-negative ESKAPEE pathogens isolated from critically ill patients in Fayoum University Hospitals, Egypt. Methods Study design This is a cross-sectional study, a descriptive molecular surveillance study conducted during the period from August 2021 to July 2022. Patients were recruited from the surgical and medical intensive care units (ICUs) of Fayoum University Hospitals. Data collection For each patient, the demographic and clinical data were reported. Collection of specimens Different types of specimens (urine, blood, endotracheal aspirate, sputum and wound swabs) were collected from the infected patients (who developed infection after 48 h or more from the hospital admission) [with clinical evidence of infection (high fever, increased leucocytic count)]. Each specimen was collected aseptically and labeled. The specimens were transferred directly to the Department of Medical Microbiology and Immunology, Faculty of Medicine, Fayoum University. Samples were cultured on Blood agar, MacConkey agar, and Bile Esculin agar [Oxoid, United Kingdom (UK)]. Also, urine samples were cultured on CLED agar (Oxoid, UK), and incubated for 24 h at 37 °C. Regarding blood samples, the samples were placed into BACTEC blood culture bottles and then incubated in the BACTEC instrument (Becton Dickinson), and continuously monitored for signs of microbial growth using advanced fluorescence detection technology. Bottles that gave positive alert were sub-cultured on solid media, such as blood agar, MacConkey agar to isolate and identify the pathogens. Identification of ESKAPEE pathogens was performed according to the standard microbiological methods (microscopic examination, motility test, and some biochemical tests) [19]. For species level: Gram-negative bacteria were further identified by MICROBACT TM GRAM-NEGATIVE Manual Biochemical reactions Identification Systems (12 A + 12B combined) (Oxoid, UK) and Gram-positive bacteria were identified to the species level using the VITEK 2 bacterial identification system (bioMérieux, USA). Antimicrobial susceptibility tests. ESKAPEE isolates were tested for antimicrobial susceptibility using the Kirby-Bauer disc diffusion method on Mueller-Hinton agar. All the inoculated plates were aerobically incubated at 37 °C for 18–24 h [20]. The used antibiotic discs (oxoid) for Gram-positive bacteria were: Penicillin (10 µg), Ampicillin (10 µg), ceftriaxone (30 µg) cefotaxime (30 µg), cefoxitin (30 µg), ciprofloxacin (5 µg), Levofloxacin (5 µg), amikacin (30 µg), azithromycin (15 µg), vancomycin (30 µg), Linezolid (30 µg), co-trimoxazole (10 µg), chloramphenicol (30 µg), and tetracycline (30 µg). For Gram-negative bacteria: Amoxicillin/Clavulanate (10/20 µg), cefoxitin (30 µg), ceftazidime (30 µg), ceftriaxone (30 µg), cefotaxime, (30 µg), cefepime (30 µg), meropenem (10 µg), Piperacillin-tazobactam (100/10 µg), ciprofloxacin (5 mg), Levofloxacin (5 µg), amikacin (30 µg), and co-trimoxazole (10 µg). The zones of growth inhibition around antibiotic discs were measured. For polymyxin B, the microdilution method was used, with the determination of the minimum inhibitory concentration (MIC) according to Clinical and Laboratory Standards Institute (CLSI) guidelines [21]. Control strains; S. aures ATCC 6538, P. aeruginosa ATCC 27,853, and E. coli ATCC 25,922; were used as a control for all antibiotics testing. Vancomycin resistance was determined by disk diffusion method, and MIC through microdilution test for Enterococci Species. Isolates with a MIC ≥ 32 µg/ml were considered to be resistant isolates. Linezolid resistance was confirmed by disk diffusion. And levofloxacin resistance was confirmed by MIC and disk diffusion [21]. For further analysis, the isolates were preserved in glycerol broth at – 80 ° C. Isolates resistant to at least one antimicrobial drug in three or more antimicrobial classes of antibiotics were considered MDR. Extensively drug resistance (XDR) was defined as non-susceptibility to at least one agent in all but two or fewer antimicrobial categories (i.e., bacterial isolates remain susceptible to only one or two categories) and pan-drug resistance (PDR) was defined as non-susceptibility to all agents in all antimicrobial categories [22]. Determination of minimum inhibitory concentration (MIC) of levofloxacin The ESKAPEE isolates with resistance to levofloxacin were tested to investigate (MIC) for levofloxacin. The test was performed in a 96-well plate with the final volume of 200 µl. Results were recorded, and susceptibility profiles were determined [23]. The antibiotic was serially diluted in concentrations ranging from 1024 µg/ml to 1 µg/ml. Each well was inoculated with 10 µl of a bacterial inoculum of 5 × 107 CFU/ml, the plates were incubated at 35˚C for 24 h under aerobic conditions [24]. Breakpoints MIC of levofloxacin for E. faecium, K. pneumonia, A. baumanii, P. aeruginosa, and E. cloace., E. coli were performed according to CLSI guidelines [20, 25]. Molecular characterization of PMQR associated genes among levofloxacin-resistant gram-negative isolates DNA from bacterial isolates was extracted by boiling method as described previously [26]. Measuring the amount of purified DNA yielded was tested using Nano Drop (ND-1000) spectrophotometer (NanoDrop Technologies, Inc. Wilmington, USA). DNA was stored in − 80∘ C until use. Each isolate was screened for 5 quinolone resistance genes (qnrA, qnrB, qnrC, qnrD, qnrS, and acc (6´)-Ib-cr). Conventional multiplex PCR assays using a Long-Gene A 200 gradient conventional PCR thermal cycler system was performed as described previously [27] to determine the presence of genes (qnrA, qnrB, and qnrS). Multiplex PCR amplification was performed with: the initial denaturation at 95˚C for 10 min, 35 cycles each cycle consisting of: denaturation at 95˚C for 1 min, annealing at 54 ˚C for 1 min, and extension at 72 ° C for 1 min. The elongation step at 72 ° C, and final step at 4 ˚C. Conventional monoplex PCR assays were performed as described previously [27] to determine the presence of genes (qnrC, qnrD) by initial denaturation at 95˚C for 10 min, followed by 31 cycles each consisting of: denaturation at 95˚C for 1 min, annealing at 55˚C for 60 s, extension at 72˚C for 60 s, and elongation step is at 72˚C for 7 min. The final step is at 4˚C. And the second monoplex PCR condition for amplification of aac(6´)-Ib-cr gene, as follows: initial denaturation at 95̊ C for 10 min, followed by 31 cycles each cycle consists of: denaturation at 95 ˚C for 60 s, annealing at 59 ˚C for 60 s, and extension at 72̊ C for 1 min. Then elongation step at 72 ˚C for 7 min. The final step is at 4˚C. Primers sequences of the used genes are shown in Table (1). Negative controls were used. PCR-amplified products were detected by gel electrophoresis and examined beneath UV light (Acculab, Canada). Table 1Primers sequence of PCR used in the studyPrimerSequenceAmplicon size (bp) qnr B F: GGMATHGAAATTCGCCACTGR: TTTGCYGYYCGCCAGTCGAA264 bp [28]. qnr S F: GCAAGTTCATTGAACAGGGTR: TCTAAACCGTCGAGTTCGGCG428 bp [28]. qnr A F: AGAGGATTTCTCACGCCAGGR: TGCCAGGCACAGATCTTGAC580 bp [28]. qnr D F: CGAGATCAATTTACGGGGAATAR: AACAAGCTGAAGCGCCTG533 bp [27]. qnr C F: GGGTTGTACATTTATTGAATCGR: CACCTACCCATTTATTTTCA307 bp [27]. aac(6´)-Ib-cr F: TTGCGATGCTCTATGAGTGGCTAR: CTCGAATGC-CTGGCGTGTTT482 bp [29]. Primers sequence of PCR used in the study F: GGMATHGAAATTCGCCACTG R: TTTGCYGYYCGCCAGTCGAA F: GCAAGTTCATTGAACAGGGT R: TCTAAACCGTCGAGTTCGGCG F: AGAGGATTTCTCACGCCAGG R: TGCCAGGCACAGATCTTGAC F: CGAGATCAATTTACGGGGAATA R: AACAAGCTGAAGCGCCTG F: GGGTTGTACATTTATTGAATCG R: CACCTACCCATTTATTTTCA F: TTGCGATGCTCTATGAGTGGCTA R: CTCGAATGC-CTGGCGTGTTT Statistical analysis Data was analyzed using Statistical Packages for Social Science (SPSS) Statistics for Windows, Version 22.0 (Armonk, NY: IBM Corp.). Descriptive statistics in the form of means, standard deviations (SD), and range were calculated for numerical data. Categorical data were described as numbers and percentages; Fisher’s exact test was used. A Spearman’s rank correlation test was used. Statistical significance was indicated at p-value < 0.05. Results Out of 446 ICU patients, 72 patients (16.1%) with suspected infection were enrolled in the study. Patients were of different age groups ranging from 18 to 88 years, the mean age was 55.9 ± 17.3. Male patients were more than female patients [42/72 (58.3%) versus 30/72 (41.7%), respectively]. Hypertension was the most common presentation in the studied patients (29/72, 40.3%) followed by diabetes mellitus (27/72, 37.5%). Distribution of the clinical samples among the patients A total of 81 samples were collected from 72 patients (2 samples were collected from each of 9 patients), of which urine was the most collected samples (33/81, 40.7%), followed by blood (18/81, 22.2%), then endotracheal aspiration (17/81, 21.0%), sputum 10/81 (12.3%), and surgical wound swab 3/81 (3.7%) (Table 2). Table 2Frequency of ESKAPEE isolates among the study samplesIsolatesBloodEndotracheal aspirateSputumSurgical swabUrineTotal N % N % N % N % N % E. faecium 00.0% 9 50% 316.6%00%633.3%18 S. aureus 5 33.3% 320%426.6%16.6%213.3%15 P. aeruginosa 213.3%426.6%213.3%00% 7 46.6% 15 K. pneumoniae 214.2% 4 28.5% 4 28.5% 17.1%321.4%14 A. baumannii 110%220%00.0%00% 7 70% 10 E. cloacae 1 100% 00.0%00.0%00%00.0%1 E. coli 0 0% 350%00.0%00.0%350%6 Total 11100%25100%13100%2100%28100%79 Frequency of ESKAPEE isolates among the study samples Flow chart of microorganisms isolated from the studied patients Out of 81 samples from 72 patients, 59 samples with significant growth yielded 84 bacterial isolates (as 2 bacterial strains were isolated from each of 25 samples): 79 (94%) were ESKAPEE isolates, and 5 (6%) were non-ESKAPEE (Fig. 1). Among ESKAPEE isolates: Gram-negative 46(58.2%) were predominant over Gram-positive organisms 33(41.8%). As well, 38 levofloxacin resistant isolates were isolated. Flow chart of microorganisms isolated from the studied patients Regarding the distribution of ESKAPEE isolates among specimens of the studied samples E. faecium was the predominant organism isolated 18/84(21.4%), followed by S. aureus and P. aeruginosa 15/ 84 (17.8%) for each. Table 2 demonstrates the frequency of ESKAPEE isolates among the study samples. Antibiotic susceptibility of ESKAPEE pathogens E. faecium was highly resistant to linezolid (100%), while S. aureus was resistant to ceftriaxone (93.3%). Less than half (about 46.7%) of S. aureus were resistant to linezolid. Regarding Gram- negative ESKAPEE pathogens, all isolates were 100% sensitive to polymyxin B. The Gram-negative bacteria showed 100% resistance to cotrimoxazole. All P. aeruginosa, A. baumannii isolates were resistant to the 3rd generation cephalosporins, and 92.9% of K. pneumoniae isolates were resistant to the 3rd generation cephalosporins. E. coli showed high resistance rates to most tested antibiotics (Tables 3 and 4). Table 3Antibiotic resistance of Gram-positive organisms among the ESKAPEE pathogensOrganismE. faecium n: 18S. aureus n: 15Antibiotic disc R N (%) R N (%)Penicillin (PEN) 18(100.0%) 12(80%)Ampicillin (AMP) 18(100.0%) 12(80%)Cefoxitin (FOX)0(0%)5(33.3%)Cefotaxime (CTX)0(0%)13(86.6%)Ceftriaxone (CRO)0(0%) 14(93.3%) Ciprofloxacin (CIP)10(55.6%)5(33.3%)Levofloxacin (LEV) 7(38.9%) 5(33.3%) Gentamicin (GN)11(61.1%)11(73.3%)Azithromycin (AZM) 18(100.0%) 12(80%)Linezolid (LNZ) 18(100.0%) 7(46.7%) Vancomycin (VAN) 14 (77.8%) 5(33.3%)Tetracycline (TE)10(55.6%)6(40%)Co-trimoxazole (COT)0(0%)12(80%)Chloramphenicol (CL)13(72.2%)6(40%)R: resistance, N: Number, %: percentage Antibiotic resistance of Gram-positive organisms among the ESKAPEE pathogens R: resistance, N: Number, %: percentage Table 4Antibiotic resistance of Gram-negative organisms among (ESKAPEE) pathogens OrganismA. baumannii n:10K. pneumoniae n:14P. aeruginosa n:15E. coli n:6Antibiotic disc R R R R N (%)N (%)N (%)N (%)Amoxicillin/Clavulanate (AMC)9(90.0%)13(92.9%)15(100.0%)6(100.0%)Cefoxitin (FOX)9(90.0%)13(92.9%)15(100.0%)6(100.0%)Cefotaxime (CTX)10(100.0%)13(92.9%)15(100.0%)6(100%)Ceftriaxone (CRO)10(100.0%)13(92.9%)15(100.0%)6(100.0%)Ceftazidime (CAZ)10(100.0%)13(92.9%)14(93.3%)6(100.0%)Cefepime, (FEB)8(80.0%)14(100.0%)12(80.0%)5(83.3%)Piperacillin + tazobactam, (TZP)9(90.0%)12(85.7%)13(86.7%)6(100.0%)Meropenem (MEM)6(60.0%)10(71.4%)12(80.0%)6(100.0%)Ciprofloxacin (CIP)5(50.0%)11(78.6%)14(93.3%)5(83.3%)Levofloxacin (LEV) 8(80.0%) 10(71.4%) 14(93.3%) 6(100%) Amikacin (AK)9(90.0%)11(78.6%)12(80.0%)4(66.7%)Gentamicin (GN)9(90.0%)12(85.7%)15(100.0%)5(83.3%)Co-trimoxazole (COT)10(100.0%)14(100.0%)15(100.0%)6(100.0%)Polymyxin B0(0%)0(0%)0(0%)0(0%)R: resistance, N: Number, %: percentage Antibiotic resistance of Gram-negative organisms among (ESKAPEE) pathogens R: resistance, N: Number, %: percentage Our results reported that 77.8% of E. faecium were VRE. Also, 80% of P. aeruginosa, 71.4% of K. pneumoniae, 83.3% of E. coli and 60% of A. baumannii were XDR isolates. The results of MIC values for Levofloxacin to different resistant organisms were between 32 to1024 µg/mL. For S. aureus isolates, all isolates had MICs > 128 µg/mL. Resistant E. faecium isolates had MICs ≥ 2 µg/mL, Regarding K. pneumoniae strains MICs were between 64 to1024 µg/mL, 90% of P. aeruginosa and E. coli MICs were > 1000 µg/mL. A. baumannii had MICs between 128 and 1024 µg/mL. As a total, the MICs of 90% of Gram-negative ESKAPEE isolates were > 1024 µg/mL (Table 5). Table 5The minimum inhibitory concentrations (MIC) of Levofloxacin against Gram-negative ESKAPEE isolatesESKAPEE isolatesMIC (µg/mL)32641282565121024> 1024 (~ 2048)MIC50MIC90K. pneumoniae (10)01133202561024P. aeruginosa (14)00002012> 1024> 1024A. baumannii (8)0022301256> 1024E.coli (6)1001301512> 1024Total (38)113611214512> 1024MIC50: the minimum inhibitory concentrations that inhibit the growth of 50% of the isolatesMIC90: the minimum inhibitory concentrations that inhibit the growth of 90% of the isolates The minimum inhibitory concentrations (MIC) of Levofloxacin against Gram-negative ESKAPEE isolates MIC50: the minimum inhibitory concentrations that inhibit the growth of 50% of the isolates MIC90: the minimum inhibitory concentrations that inhibit the growth of 90% of the isolates Frequency of plasmid-mediated quinolone resistance genes in Gram negative isolates Regarding the type of PMQR detecte, qnr B [ (30/38) 78.9%] was the most frequently detected gene among ESKAPEE pathogens, followed by qnr D [ (26/38) 68.4%], then Aac (6´)-Ib-cr [(19/38) 50%]. 100%, 70.0%, 66.7% of P. aeruginosa, K. pneumoniae, and A. baumannii had qnr B genes, respectively (Table 6). Table 6Type of plasmid-mediated quinolone resistance genes among gram negative ESKAPEE isolatesGenesTotalA. baumannii N:8K. pneumoniae N:10P. aeruginosa N:14E. coli N:6 N % N % (95% CI) N % (95% CI) N % (95% CI) N % (95% CI)P-value Qnr A 1436.8%222.2% (6.3%-54.7%)550.0% (23.7%-76.3%)646.2% (23.2%-70.9%)116.7%0.374 Qnr B 3078.9%666.7% (35.4%-87.9%)770.0% (39.7%-89.2%)13100.0%466.7%0.270 Qnr S 1539.5444.4% (18.9%-73.3%)330.0% (10.8%-60.3%)646.2% (23.2%-70.9%)233.3%0.652 Qnr D 2668.4%444.4% (18.9%-73.3%)550.0% (23.7%-76.3%)13100.0%466.7% 0.047* Qnr C 0000000000 Acc (6´)-Ib-cr 1950%444.4% (18.9%-73.3%)440.0% (16.8%-68.7%)969.2% (42.4–87.3%)233.3%0.420N: number, %: percentage. *p-value < 0.05 Type of plasmid-mediated quinolone resistance genes among gram negative ESKAPEE isolates N: number, %: percentage. *p-value < 0.05 As shown in Fig. 2, thirty-eight ESKAPEE levofloxacin resistance isolates were analyzed, 11/38 isolates (28.9%) had 3 Qnr genes while 2 isolates (5.3%) did not have any of tested genes. Number of plasmids mediated quinolone resistance gene among ESKAPEE isolates When investigating the association between the number of genes present and the MICs of levofloxacin, a highly significant positive correlation was detected (r = 0. 86, P < 0.000). Isolates carrying 4 or more genes have MIC values of 512 or more (Table 7). Table 7The minimum inhibitory concentrations (MIC) of Levofloxacin in relation to number of PMQR genesNumber of detected genes in ESKAPEE isolatesMIC (µg/mL)32641282565121024> 1024 (~ 2048)011121214413155422454 The minimum inhibitory concentrations (MIC) of Levofloxacin in relation to number of PMQR genes Discussion ESKAPEE pathogens are among the most common bacterial organisms causing HAIs. Continuous attention to the ESKAPEE organisms can help us in combating the wide challenge of antibiotic resistance, and find proper combined antimicrobial therapy [30]. In the current work, the isolated ESKAPEE organisms were responsible for 94% of all bacterial clinical ICU isolates. Arbune et al. [31] found that ESKAPEE pathogens were found in more than 97% of the bacterial isolates, which is nearly similar to our result. A study by Flores-Paredes et al. [32] reported that ESKAPE pathogens represented 51% of the bacterial isolates, which is much lower than our result. This may be partially explained by their not including E.coli in the prevalence rate of their study. According to Saharman et al. [33], the distribution of ESKAPEE pathogens varies across different areas in lower-middle-income countries. This may be, in part, a reason for the variability between studies. Among ESKAPEE pathogens, we detected the predominance of Gram-negative bacteria (58.2%) over Gram-positive organisms. This was slightly less than the study conducted by Gemechu et al. [34], who found that the Gram-negative bacteria accounted for 69.4%. At the same line, Llaca-Díaz et al. [35] emphasized that Gram-negative bacteria constituted the most prevalent group of nosocomial pathogens in the ICUs. Also, Rothe et al. [36] stated that the most frequently recovered organisms from ICU were ESKAPEE pathogens, with a predominance of Gram-negative bacteria (A. baumannii, P. aeruginosa, and K. pneumonia). The overuse and abuse of antibacterial drugs have led to wasting their potential as valuable tools. Antibiotics increase selection pressure on humans and microbiota, favoring the survival of microorganisms with antibiotic resistance determinants. These resistant microorganisms are the winners in the antibiotic-age race for bacterial survival [37]. Our results revealed that 77.8% of E. faecium were VRE. Also, 80% of P. aeruginosa, 71.4% of K. pneumoniae, 83.3% of E. coli and 60% of A. baumannii were XDR isolates. Kritsotakis et al. [38] isolated ESKAPEE bacteria from bloodstream infection in Greece, and found A. baumannii isolates were highly Resistant (> 80% to 100%) to all agents tested except colistin, and about 20% of the isolates were XDR, of which four isolates are considered PDR. Extensively drug-resistant (XDR) A. baumannii infections have ranged from 24% to 83% [39]. In Spain, it was found that about 26% of P. aeruginosa isolates were MDR, and 65% of them met the criteria for XDR classification; most were sensitive only to colistin and amikacin [40]. The high rate of fluoroquinolone resistance in the present study guided us to investigate the prevalence of the PMQR genes among the Gram-negative ESKAPEE isolates. Our study revealed that almost all Gram-negative quinolone-resistant ESKAPEE bacteria had qnr genes. Most tested isolates (86.8%) have more than one PMQR gene. This agrees with the findings of Kariuki et al. [41] who found over 80% of the isolates had at least one PMQR gene identified. P. aeruginosa are resistant to the fluoroquinolones in this study. The resistance can be explained by the existence of three PMQR genes in 46% of isolates, four genes in 23% of isolates and five genes in 23% of isolates, i.e., 92% of isolates in the present study had PMQR genes. The present findings agree with the findings of Nejma et al. [42] as the highest resistance rates among P. aeruginosa isolates were found for ciprofloxacin (100%). In Egypt, El-Badawy et al. [43] found that qnrB was the most detected gene and 74% of K. pneumoniae clinical isolates tested positive for this gene. This agrees with our data as qnrB was the most frequently detected gene present in ESKAPEE pathogens (78.9%). qnrB are common in Egyptian hospitals as in Abdel-Rhman et al. [44] who detected the prevalence of quinolone resistance among E. coli isolates and reported the high prevalence of PMQR genes among isolates. Also, in Iran, Jomehzadeh et al. [45] found that 65% of isolates harbored multiple PMQR genes. Amin et al. [46] found increased qnrB gene. Also, in our result, qnr S, which represented 39.5% more than qnr A (36.8%), which are in agreement with Mashaly et al. [47] in Egypt, who found qnr S was more prevalent than qnrA of K. pneumoniae isolates in ICU patients. Al-Agamy et al. [48] described that qnrS was the dominant PMQR genes in K. pneumoniae and E.coli isolates. The AAC (6’)- Ib-cr represented 50% which agrees with El-Badawy et al. [43] in Egypt, their results revealed that 61% (35/57) of aac(6’)-Ib-cr of quinolone-resistant K. pneumoniae isolates tested positive for aac(6’)-Ib-cr. Jomehzadeh et al. [49] found that coexistence of aac (6’)-Ib-cr variant and qnrB was the most distributed genotype among quinolone resistance E. coli isolates. In the present study qnr D was detected (68.4%), and only 2 isolates 5.3% did not have qnr genes similar results were seen in El-Badawy et al. [50] in Saudi Arabia, as qnrD, were found in79.5% of Pseudomonas isolates, also 5.1% (2/39) of the isolates did not contain any of the tested PMQR genes. The present results detected a significantly positive correlation in ESKAPEE pathogens and the MICs of Levofloxacin (r = 0.68, P = 0.000), and isolates carrying 4 or more genes have MIC values of 512 or more. In agreement with these results, El-Badawy et al. [43], found that K. pneumoniae isolates that harbored more than 2 c (qnrB and acc(6′)-Ib) showed elevated MICs (16 to 256 µg/ml) for ciprofloxacin and levofloxacin. However, the MICs in the present study are still higher; this may be explained by the increased frequency of detected genes in the current study. It should be noted that higher levels of quinolone resistance are seen if a strain carries two or more genes for quinolone resistance [11]. Previous studies have investigated the frequencies of PMQR genes in one or two members of ESKAPEE group, and, to our knowledge, this is the first study that investigates these genes in all Gram-negative members of this group in ICU setting. The ESKAPEE group is of particular concern due to its remarkable ability to evade antibiotic treatment regimens and its major role in causing healthcare associated infections especially in ICU patients [51].Fluoroquinolones remain one of the most important options in the treatment of many Gram-negative and some Gram-positive infections, but due to rapid development of resistance, there is steadily reduction in their clinical use which highlights the precising need to develop new antimicrobial agents [11, 51]. To save old antimicrobial agents, continuous surveillance, application of antimicrobial stewardship program and effective infection control measures are critical to limit the spread of drug-resistant bacteria in healthcare settings. Limitations of the study The present study has some limitations. First, this is a single-Centre study with limited generalizability, and the small sample sizes. Second, the study investigates the PMQR-associated genes among levofloxacin-resistant gram-negative ESKAPEE pathogens and did not investigate other chromosomal or efflux pump resistant genes with the lack of direct plasmid characterization. In addition, MIC confirmation was not performed for linezolid. Third, the study did not evaluate the clinical impact of PMQR genes on patient outcome as mortality and length of hospital stay. Future researches are needed to cover the whole aspects of resistance in ESKAPEE group of bacteria. Conclusions The isolated ESKAPEE organisms were responsible for 94% of all bacterial isolates. PMQR-associated genes were frequently detected among levofloxacin-resistant Gram-negative ESKAPEE isolates in our ICU setting. qnrB was the most frequently detected gene. Surveillance and Strict application of infection control measures are crucial to prevent the increase of resistant genes among bacteria. Additionally, Standard infection control and antimicrobial stewardship programs should be reinforced to ensure appropriate antibiotic use. Abbreviations Plasmid-Mediated Quinolone Resistant E. faecium, S. aureus, K. pneumoniae, A. baumannii, P. aeruginosa, Enterobacter species, E. coli Minimum inhibitory concentration The Minimum inhibitory concentrations that inhibit the growth of 50% of the isolates The Minimum inhibitory concentrations that inhibit the growth of 90% of the isolates Polymerase chain reaction Multidrug-resistant Pan-drug-resistant Extensive-drug-resistant Author contributions S.N.G, H. S., M. A.K, and H. M. Wrote the manuscript, and contributed to the actual laboratory work., A.F. clinical diagnosis of infections, R.H.B., A.A.W., and J.M Reviewed and edited the manuscript. Funding The authors received no specific funding for this work. Data availability No datasets were generated or analysed during the current study. Declarations Ethics approval and consent to participate The objectives and procedures of the study were approved by the Fayoum University Ethics Committee No: D249, Date 11-7-2021 Written informed consents were obtained from all participants after a clear clarification of the study’s objectives. The study was conducted according to the principles of the Declaration of Helsinki. All methods were performed in accordance with relevant guidelines and regulations. Consent for publication All authors have approved the final version of the manuscript for publication. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement No datasets were generated or analysed during the current study.